2025
Effectiveness of the TAK-003 dengue vaccine in adolescents during the 2024 outbreak in São Paulo, Brazil: a test-negative, case–control study
Ranzani O, Lazar Neto F, Mareto L, Brumatti T, de Oliveira R, da Silva P, Dos Santos E, D' Agostini T, De Paula R, Dean N, Ko A, Cummings D, Andrews J, Hitchings M, Croda J. Effectiveness of the TAK-003 dengue vaccine in adolescents during the 2024 outbreak in São Paulo, Brazil: a test-negative, case–control study. The Lancet Infectious Diseases 2025 PMID: 40845862, DOI: 10.1016/s1473-3099(25)00382-2.Peer-Reviewed Original ResearchAcute febrile illnessCase-control studyTAK-003Vaccine effectivenessSymptomatic dengueFirst doseSecond doseFebrile illnessDengue vaccineReal-world evidenceTest-negativeDays of symptom onsetTetravalent dengue vaccinePublic health challengeHigh-transmission settingsLogistic regression modelsDengue virus serotype 1National surveillance databaseSao PauloRT-PCR testHealth challengesSymptomatic diseaseGlobal health threatNS1 antigenSurveillance database
2022
Effectiveness of an inactivated Covid-19 vaccine with homologous and heterologous boosters against Omicron in Brazil
Ranzani OT, Hitchings MDT, de Melo RL, de França GVA, Fernandes CFR, Lind ML, Torres MSS, Tsuha DH, David LCS, Said RFC, Almiron M, de Oliveira RD, Cummings DAT, Dean NE, Andrews JR, Ko AI, Croda J. Effectiveness of an inactivated Covid-19 vaccine with homologous and heterologous boosters against Omicron in Brazil. Nature Communications 2022, 13: 5536. PMID: 36202800, PMCID: PMC9537178, DOI: 10.1038/s41467-022-33169-0.Peer-Reviewed Original Research
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply